TAM
NVCR icon

Tucker Asset Management’s NovoCure NVCR Stock Holding History

Tucker Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,600
Closed -$27.4K – 1607
2024
Q2 		$27.4K Buy
+1,600
New +$28.1K 0.01% 529

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tucker Asset Management's NVCR Position: Q3 2024 in Review

Tucker Asset Management sold out of NovoCure (NVCR) in Q3 2024, closing a stake of 1,600 shares — an estimated $27.4K sold.

Tucker Asset Management first reported a position in NVCR in Q2 2024 and held it in 1 quarter. The position peaked at $27.4K in Q2 2024. 224 funds tracked by Wall St. Rank hold NVCR as of Q3 2024.

  • Tucker Asset Management reported no remaining NovoCure position as of Q3 2024 after selling out during the quarter.
  • Tucker Asset Management sold 1,600 NovoCure shares in Q3 2024, an estimated $27.4K.
  • Tucker Asset Management first reported a position in NovoCure in Q2 2024 and held it in 1 quarter.
  • Tucker Asset Management's NovoCure position peaked at $27.4K in Q2 2024.
  • 224 funds tracked by Wall St. Rank held NovoCure as of Q3 2024.

Based on Tucker Asset Management's 13F filing for Q3 2024, filed 3 Feb 2025.